+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

mBio Diagnostics Inc - Product Pipeline Analysis, 2020 Update

  • PDF Icon

    Company Profile

  • 29 Pages
  • June 2020
  • GlobalData
  • ID: 4539804
Summary

MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a single sample. The company’s products are used in clinical and analytical testing applications across medical, veterinary, agricultural, environmental, food, and military markets. It operates biosafety laboratories in Boulder for biological assay development, method development and validation. MBio is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company mBio Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

mBio Diagnostics Inc Company Overview
  • mBio Diagnostics Inc Company Snapshot
  • mBio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • mBio Diagnostics Inc – Pipeline Analysis Overview
  • mBio Diagnostics Inc - Key Facts
  • mBio Diagnostics Inc - Major Products and Services
  • mBio Diagnostics Inc Pipeline Products by Development Stage

mBio Diagnostics Inc Pipeline Products Overview
  • Blood Transfer Device
  • Blood Transfer Device Product Overview
  • Diagnostic Test - Flu
  • Diagnostic Test - Flu Product Overview
  • MBio 5-plex Assay
  • MBio 5-plex Assay Product Overview
  • MBio Array System
  • MBio Array System Product Overview
  • mBio Diagnostic Assay - Tuberculosis
  • mBio Diagnostic Assay - Tuberculosis Product Overview
  • Multi-Marker Blood Test - Radiation Exposure
  • Multi-Marker Blood Test - Radiation Exposure Product Overview
  • POC Diagnostic Device - Malaria
  • POC Diagnostic Device - Malaria Product Overview
  • Point of Care Device - HIV
  • Point of Care Device - HIV Product Overview
  • Rapid Diagnostic Test - Anthrax
  • Rapid Diagnostic Test - Anthrax Product Overview
  • mBio Diagnostics Inc - Key Competitors
  • mBio Diagnostics Inc - Key Employees
  • mBio Diagnostics Inc - Locations And Subsidiaries
  • Head Office

Recent Developments
  • mBio Diagnostics Inc, Recent Developments
  • Jan 14, 2020: MBio Diagnostics announces new contracts with SRI
  • Aug 01, 2019: MBio Diagnostics announces two contracts for sepsis test development
  • Feb 14, 2018: DARPA Awards MBio Diagnostics Phase II Contract for Acute Infection Point-of-Care System
  • Jan 04, 2018: MBio Diagnostics Expands IP Portfolio - Announces Issuance of Two New Patents
  • Feb 18, 2016: MBio Diagnostics Announces Issuance of Two New Patents
  • Sep 14, 2015: MBio Diagnostics Presenting at Upcoming Conferences
  • Mar 16, 2015: MBio Diagnostics Rapid Detection Platform Validated in Independent Study
  • Nov 04, 2014: MBio Diagnostics Awarded Contract for Diagnostic Development With the U.S. Army
  • May 05, 2014: MBio Diagnostics Awarded Patent for Improved Analyte Detection
  • Mar 11, 2014: MBio Diagnostics Presents Tuberculosis Study Results

Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer

List of Tables
  • mBio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • mBio Diagnostics Inc Pipeline Products by Equipment Type
  • mBio Diagnostics Inc Pipeline Products by Indication
  • mBio Diagnostics Inc, Key Facts
  • mBio Diagnostics Inc, Major Products and Services
  • mBio Diagnostics Inc Number of Pipeline Products by Development Stage
  • mBio Diagnostics Inc Pipeline Products Summary by Development Stage
  • Blood Transfer Device - Product Status
  • Blood Transfer Device - Product Description
  • Diagnostic Test - Flu - Product Status
  • Diagnostic Test - Flu - Product Description
  • MBio 5-plex Assay - Product Status
  • MBio 5-plex Assay - Product Description
  • MBio Array System - Product Status
  • MBio Array System - Product Description
  • mBio Diagnostic Assay - Tuberculosis - Product Status
  • mBio Diagnostic Assay - Tuberculosis - Product Description
  • Multi-Marker Blood Test - Radiation Exposure - Product Status
  • Multi-Marker Blood Test - Radiation Exposure - Product Description
  • POC Diagnostic Device - Malaria - Product Status
  • POC Diagnostic Device - Malaria - Product Description
  • Point of Care Device - HIV - Product Status
  • Point of Care Device - HIV - Product Description
  • Rapid Diagnostic Test - Anthrax - Product Status
  • Rapid Diagnostic Test - Anthrax - Product Description
  • mBio Diagnostics Inc, Key Employees
  • Glossary

List of Figures
  • mBio Diagnostics Inc Pipeline Products by Equipment Type
  • mBio Diagnostics Inc Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arrayit Diagnostics, Inc.
  • Dexall Biomedical Labs Inc
  • Diamedix Corp